Form 8-K Zymeworks Inc. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Zymeworks (ZYME) Removes its CFO
April 1, 2024 9:06 AM EDTOn March 31, 2024, Zymeworks (NASDAQ: ZYME) removed Dr. Christopher Astle from the positions of Senior Vice President and Chief Financial Officer, including as the Companys principal financial officer and principal accounting officer, effective immediately.
In connection with Dr. Astles removal, effective March 31, 2024,... More
